These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11682296)

  • 1. Fast 3D dynamic MR imaging of the liver with MR SmartPrep: comparison with helical CT in detecting hypervascular hepatocellular carcinoma.
    Tomemori T; Yamakado K; Nakatsuka A; Sakuma H; Matsumura K; Takeda K
    Clin Imaging; 2001; 25(5):355-61. PubMed ID: 11682296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity in detection of hypervascular hepatocellular carcinoma by helical CT with intra-arterial injection of contrast medium, and by helical CT and MR imaging with intravenous injection of contrast medium.
    Hori M; Murakami T; Oi H; Kim T; Takahashi S; Matsushita M; Tomoda K; Narumi Y; Kadowaki K; Nakamura H
    Acta Radiol; 1998 Mar; 39(2):144-51. PubMed ID: 9529444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of hepatocellular carcinoma: comparison of dynamic MR imaging with dynamic double arterial phase helical CT.
    Noguchi Y; Murakami T; Kim T; Hori M; Osuga K; Kawata S; Kumano S; Okada A; Sugiura T; Nakamura H
    AJR Am J Roentgenol; 2003 Feb; 180(2):455-60. PubMed ID: 12540451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small hepatocellular carcinomas in cirrhosis: differences in contrast enhancement effects between helical CT and MR imaging during multiphasic dynamic imaging.
    Hayashida M; Ito K; Fujita T; Shimizu A; Sasaki K; Tanabe M; Matsunaga N
    Magn Reson Imaging; 2008 Jan; 26(1):65-71. PubMed ID: 17566685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging.
    Motosugi U; Ichikawa T; Sou H; Sano K; Tominaga L; Muhi A; Araki T
    Radiology; 2010 Jul; 256(1):151-8. PubMed ID: 20574092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of hypervascular hepatocellular carcinoma by dynamic magnetic resonance imaging with double-echo chemical shift in-phase and opposed-phase gradient echo technique: comparison with dynamic helical computed tomography imaging with double arterial phase.
    Noguchi Y; Murakami T; Kim T; Hori M; Osuga K; Kawata S; Okada A; Sugiura T; Tomoda K; Narumi Y; Nakamura H
    J Comput Assist Tomogr; 2002; 26(6):981-7. PubMed ID: 12488747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small hepatocellular carcinoma in patients with chronic liver damage: prospective comparison of detection with dynamic MR imaging and helical CT of the whole liver.
    Yamashita Y; Mitsuzaki K; Yi T; Ogata I; Nishiharu T; Urata J; Takahashi M
    Radiology; 1996 Jul; 200(1):79-84. PubMed ID: 8657948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detectability of hypervascular hepatocellular carcinoma by arterial phase images of MR and spiral CT.
    Murakami T; Kim T; Oi H; Nakamura H; Igarashi H; Matsushita M; Okamura J; Kozuka T
    Acta Radiol; 1995 Jul; 36(4):372-6. PubMed ID: 7619614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidetector row CT and MR imaging in diagnosing hepatocellular carcinoma.
    Murakami T; Hori M; Kim T; Kawata S; Abe H; Nakamura H
    Intervirology; 2004; 47(3-5):209-26. PubMed ID: 15383731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of hypervascular hepatocellular carcinoma: comparison of SPIO-enhanced MRI with dynamic helical CT.
    Hori M; Murakami T; Kim T; Tsuda K; Takahashi S; Okada A; Takamura M; Nakamura H
    J Comput Assist Tomogr; 2002; 26(5):701-10. PubMed ID: 12439302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-dimensional dynamic liver MR imaging using sensitivity encoding for detection of hepatocellular carcinomas: comparison with superparamagnetic iron oxide-enhanced mr imaging.
    Kim YK; Kim CS; Kwak HS; Lee JM
    J Magn Reson Imaging; 2004 Nov; 20(5):826-37. PubMed ID: 15503325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
    Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
    Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal scan timing of hepatic arterial-phase imaging of hypervascular hepatocellular carcinoma determined by multiphasic fast CT imaging technique.
    Kagawa Y; Okada M; Yagyu Y; Kumano S; Kanematsu M; Kudo M; Murakami T
    Acta Radiol; 2013 Oct; 54(8):843-50. PubMed ID: 23761547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic MR imaging and early-phase helical CT for detecting small intrahepatic metastases of hepatocellular carcinoma.
    Oi H; Murakami T; Kim T; Matsushita M; Kishimoto H; Nakamura H
    AJR Am J Roentgenol; 1996 Feb; 166(2):369-74. PubMed ID: 8553950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of diagnostic enhancement pattern in hepatocellular carcinoma nodules ≤2 cm according to the AASLD/EASL revised criteria.
    Quaia E; De Paoli L; Angileri R; Pizzolato R; Cabibbo B; Cova MA
    Abdom Imaging; 2013 Dec; 38(6):1245-53. PubMed ID: 24026173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of hypervascular malignant foci in borderline lesions of hepatocellular carcinoma: comparison of dynamic multi-detector row CT, dynamic MR imaging and superparamagnetic iron oxide-enhanced MR imaging.
    Shinmura R; Matsui O; Kadoya M; Kobayashi S; Terayama N; Sanada J; Demachi H; Gabata T
    Eur Radiol; 2008 Sep; 18(9):1918-24. PubMed ID: 18386012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detecting hepatocellular carcinoma: value of unenhanced or arterial phase CT imaging or both used in conjunction with conventional portal venous phase contrast-enhanced CT imaging.
    Oliver JH; Baron RL; Federle MP; Rockette HE
    AJR Am J Roentgenol; 1996 Jul; 167(1):71-7. PubMed ID: 8659425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Will CT take second billing to MR imaging for the diagnosis of hypervascular hepatocellular carcinomas hereafter?
    Kanematsu M
    Radiology; 2011 Aug; 260(2):607; author reply 607-8. PubMed ID: 21778455
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of double-arterial phase gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced liver magnetic resonance imaging compared with double-arterial phase multi-detector row helical computed tomography.
    Akai H; Kiryu S; Takao H; Tajima T; Shibahara J; Imamura H; Kokudo N; Akahane M; Ohtomo K
    J Comput Assist Tomogr; 2009; 33(6):887-92. PubMed ID: 19940656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual double arterial phase dynamic MR imaging with sensitivity encoding (SENSE): which is better for diagnosing hypervascular hepatocellular carcinomas, in-phase or opposed-phase imaging?
    Yoshioka H; Sato J; Takahashi N; Lou D; Yamaguchi M; Saida Y; Itai Y
    Magn Reson Imaging; 2004 Apr; 22(3):361-7. PubMed ID: 15062931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.